Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart
暂无分享,去创建一个
J. Port | A. Feldman | M. White | M. Bristow | F. Anderson | W. Minobe | R. Roden | D. Campbell | P. Larrabee | M. Wollmering | M. F. Khan
[1] Y. Shu,et al. Forskolin Binding Sites and G‐Protein Immunoreactivity in Rat Hearts During Aging , 1994, Journal of cardiovascular pharmacology.
[2] D. Renlund,et al. Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts. , 1993, Journal of the American College of Cardiology.
[3] H. Bourne,et al. Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. , 1993, The Journal of biological chemistry.
[4] M. Y. Degtyarev,et al. Increased palmitoylation of the Gs protein alpha subunit after activation by the beta-adrenergic receptor or cholera toxin. , 1993, The Journal of biological chemistry.
[5] A. Ng,et al. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. , 1993, Hypertension.
[6] D. Bernstein,et al. Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. , 1993, Journal of Biological Chemistry.
[7] M. Cerqueira,et al. Differences in Cardiovascular Responses to Isoproterenol in Relation to Age and Exercise Training in Healthy Men , 1992, Circulation.
[8] John O. Holloszy,et al. Effects of Aging, Sex, and Physical Training on Cardiovascular Responses to Exercise , 1992, Circulation.
[9] S. Pyne,et al. Phosphorylation of the recombinant spliced variants of the alpha-sub-unit of the stimulatory guanine-nucleotide binding regulatory protein (Gs) by the catalytic sub-unit of protein kinase A. , 1992, Biochemical and biophysical research communications.
[10] A. Branzi,et al. Biochemical correlates with myocardial aging. , 1992, Cardioscience.
[11] F. del Monte,et al. Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. , 1992, Journal of molecular and cellular cardiology.
[12] J. Port,et al. Effect of Therapeutic Dopamine Administration on Myocardial Catecholamine and Neuropeptide Y Concentrations in the Failing Ventricles of Patients with Idiopathic Dilated Cardiomyopathy , 1992, Journal of Cardiovascular Pharmacology.
[13] L. Mestroni,et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. , 1992, The Journal of clinical investigation.
[14] D. Kass,et al. Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. , 1992, Circulation research.
[15] M. Michel,et al. Spare Receptors for β‐Adrenoceptor-Mediated Positive Inotropic Effects of Catecholamines in the Human Heart , 1992, Journal of cardiovascular pharmacology.
[16] J. Port,et al. Myocardial Catecholamine and Neuropeptide Y Depletion in Failing Ventricles of Patients With Idiopathic Dilated Cardiomyopathy: Correlation With β‐Adrenergic Receptor Downregulation , 1992, Circulation.
[17] J. Rouleau,et al. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. , 1991, Journal of the American College of Cardiology.
[18] J. Halter,et al. Effect of desipramine on norepinephrine metabolism in humans: interaction with aging. , 1991, The American journal of physiology.
[19] D. Kitzman,et al. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. , 1991, Journal of the American College of Cardiology.
[20] A. Feldman,et al. Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. , 1991, Journal of molecular and cellular cardiology.
[21] D. Ferguson,et al. Resting muscle sympathetic nerve activity correlates with right rather than left ventricular ejection fraction in human heart failure , 1991 .
[22] M. White,et al. Cardiac beta receptors and baroreflex responses with aging , 1991 .
[23] P. Armstrong,et al. Fibrillar collagen and remodeling of dilated canine left ventricle. , 1990, Circulation.
[24] F. Romano,et al. Increased myocardial adenosine production and reduction of beta-adrenergic contractile response in aged hearts. , 1990, Circulation research.
[25] K. Shigenobu,et al. Role of β‐adrenoceptor‐adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart , 1990, British journal of pharmacology.
[26] P. Scarpace. Forskolin activation of adenylate cyclase in rat myocardium with age: Effects of guanine nucleotide analogs , 1990, Mechanisms of Ageing and Development.
[27] S. Vatner,et al. Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor. , 1989, The Journal of clinical investigation.
[28] R. Hershberger,et al. Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density. , 1989, Circulation research.
[29] E. Lakatta,et al. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. , 1989, The American journal of physiology.
[30] W. Simonds,et al. Receptor and effector interactions of Gs Functional studies with antibodies to the αs carboxyl‐terminal decapeptide , 1989, FEBS letters.
[31] M. Bristow,et al. Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? , 1989, European heart journal.
[32] E. Sonnenblick,et al. Effects of age on mechanical and structural properties of myocardium of Fischer 344 rats. , 1989, The American journal of physiology.
[33] J. Port,et al. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.
[34] A. Katz,et al. The myocardium in congestive heart failure. , 1989, The American journal of cardiology.
[35] W. Baumgartner,et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.
[36] J. J. Beckeringh,et al. Selective regulation of β1‐and β2‐adrenoceptors in the human heart by chronic β‐adrenoceptor antagonist treatment , 1988 .
[37] M. Bristow,et al. Myocardial α- and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? , 1988 .
[38] H. Bittiger,et al. CGP 20712 A: a useful tool for quantitating β1- and β2-adrenoceptors , 1986 .
[39] M. Dufau,et al. Inhibitory action of forskolin on adenylate cyclase activity and cyclic AMP generation. , 1986, The Journal of biological chemistry.
[40] T. Miller,et al. Left ventricular diastolic filling and its association with age. , 1986, The American journal of cardiology.
[41] S. Jamieson,et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.
[42] A. Gilman,et al. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. , 1986, The Journal of biological chemistry.
[43] P. de Neef,et al. Alterations of rat cardiac adenylate cyclase activity with age. , 1986, European journal of pharmacology.
[44] R. Coleman,et al. Physiologic basis for the age-related decline in aerobic work capacity. , 1986, The American journal of cardiology.
[45] O. Brodde,et al. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. , 1986, Science.
[46] J. Roberts,et al. The Effect of Age on the Tyramine-Sensitive Intraneuronal Pool of Norepinephrine in Rat Heart , 1986, Journal of cardiovascular pharmacology.
[47] J. Fleg,et al. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. , 1985, Journal of applied physiology.
[48] R. Ebstein,et al. Deterioration of beta-receptor-adenylate cyclase function in elderly, hospitalized patients. , 1984, Journal of gerontology.
[49] M. Bristow,et al. Pharmacology and inotropic potential of forskolin in the human heart. , 1984, The Journal of clinical investigation.
[50] M. Caron,et al. Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. , 1984, Physiological reviews.
[51] R. Feldman,et al. Alterations in leukocyte β-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly , 1984 .
[52] J. Fleg,et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. , 1984, Circulation.
[53] J. Pitha,et al. Decreased response with age of the cardiac catecholamine sensitive adenylate cyclase system. , 1983, Life sciences.
[54] L. Rubenstein,et al. Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. , 1983, Journal of gerontology.
[55] I. Abrass,et al. Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes. , 1982, The Journal of clinical endocrinology and metabolism.
[56] L. Mahan,et al. Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. , 1982, The Journal of biological chemistry.
[57] J. Kelly,et al. Human Lymphocyte β‐Adrenoceptor Density in Relation to Age and Hypertension , 1982 .
[58] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[59] J. Kelly,et al. Sodium fluoride activation of human lymphocyte adenylate cyclase is reduced in old age. , 1982, British journal of clinical pharmacology.
[60] N. Narayanan,et al. Alterations in the properties of β-adrenergic receptors of myocardial membranes in aging: Impairments in agonist—receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylated cyclase , 1982, Mechanisms of Ageing and Development.
[61] R. Landmann,et al. High affinity beta-2-adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects. , 1981, Life sciences.
[62] J. Kelly,et al. Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. , 1981, British journal of clinical pharmacology.
[63] E. Braunwald,et al. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.
[64] D. Robertson,et al. Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. , 1981, The Journal of clinical investigation.
[65] I. Abrass,et al. Age-associated decrease of adenylate cyclase activity in rat myocardium , 1981, Mechanisms of Ageing and Development.
[66] I. Abrass,et al. Human lymphocyte beta-adrenergic receptors are unaltered with age. , 1981, Journal of gerontology.
[67] J. Krall,et al. Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase. , 1981, The Journal of clinical endocrinology and metabolism.
[68] J. L. Martínez,et al. Age-related changes in the catecholamine content of peripheral organs in male and female F344 rats. , 1981, Journal of gerontology.
[69] E. Rappaport,et al. Impact of age on basal and diet-induced changes in sympathetic nervous system activity of Fischer rats. , 1981, Journal of gerontology.
[70] A. Gilman,et al. Purification of the regulatory component of adenylate cyclase. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[71] E. Neer,et al. Properties of the separated catalytic and regulatory units of brain adenylate cyclase. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[72] E. Lakatta,et al. Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. , 1980, The American journal of physiology.
[73] K. O'malley,et al. Age and beta adrenoceptor–mediated function , 1980, Clinical pharmacology and therapeutics.
[74] R. Vestal,et al. Reduced β‐adrenoceptor sensitivity in the elderly , 1979 .
[75] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[76] G. Peterson,et al. A simplification of the protein assay method of Lowry et al. which is more generally applicable. , 1977, Analytical biochemistry.
[77] E. Lakatta,et al. Echocardiographic Assessment of a Normal Adult Aging Population , 1977, Circulation.
[78] I. Kopin,et al. Plasma noradrenaline increases with age , 1976, Nature.
[79] W Grossman,et al. Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.
[80] C. Londos,et al. A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.
[81] J. Covell,et al. Left Ventricular Dilatation and Diastolic Compliance Changes during Chronic Volume Overloading , 1972, Circulation.
[82] E. Braunwald,et al. CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.
[83] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[84] A. Wellstein,et al. Differentiation of β1- and β2-adrenoceptor-mediated effects in humans , 1988 .
[85] S. Banerjee,et al. Age-related reduction of beta-adrenoceptor sensitivity in rat heart occurs by multiple mechanisms. , 1985, Gerontology.
[86] G. Piazzesi,et al. Influences of age on the positive inotropic effect mediated by alpha- and beta-adrenoceptors in rat ventricular strips. , 1985, Developmental pharmacology and therapeutics.
[87] G. Piazzesi,et al. Influences of age on the positive inotropic effect mediated by α- and β-adrenoceptors in rat ventricular strips , 1985 .
[88] M. Laks,et al. Norepinephrine increases beta-receptors and adenylate cyclase in canine myocardium. , 1984, The American journal of physiology.
[89] O. Brodde. Endogenous and Exogenous Regulation of Human α- and β-Adrenergic Receptors , 1983 .
[90] N. Narayanan,et al. Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. , 1982, Mechanisms of ageing and development.
[91] B. Wallin,et al. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. , 1981, Acta physiologica Scandinavica.